Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms

Endocrinology

Volumn 149, Issue 3, 2008, Pages 1180-1189

  Banu, S K ^a   Lee, J ^a   Speights Jr , V O ^b   Starzinski Powitz, A ^c   Arosh, Joe A ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROSTAGLANDIN E2;

ARTICLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE CONTROL; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL;

APOPTOSIS; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; POLY(ADP-RIBOSE) POLYMERASES; RNA, SMALL INTERFERING; STROMAL CELLS;

EID: 40849106617     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1168     Document Type: Article

References (52)

1. Garai J, Molnar V, Varga T, Koppan M, Torok A, Bodis J 2006 Endometriosis: harmful survival of an ectopic tissue. Front Biosci 11:595-619
2. Farquhar C 2007 Endometriosis. BMJ 334:249-253
3. Wu MH, Shoji Y, Chuang PC, Tsai SJ 2007 Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med 9:1-20
4. Hastings JM, Fazleabas AT 2006 A baboon model for endometriosis: implications for fertility. Reprod Biol Endocrinol 4(Suppl 1):S7
5. Osteen KG, Bruner-Tran KL, Eisenberg E 2005 Endometrial biology and the etiology of endometriosis. Fertil Steril 84:33-34; discussion 38-39
6. Attar E, Bulun SE 2006 Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril 85:1307-1318
7. Sampson J 1927 Peritoneal endometritis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:442-469
8. Zeitvogel A, Baumann R, Starzinski-Powitz A 2001 Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model. Am J Pathol 159:1839-1852
9. Lucidi RS, Witz CA, Chrisco M, Binkley PA, Shain SA, Schenken RS 2005 A novel in vitro model of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells. Fertil Steril 84:16-21
10. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S 2002 Estrogen production and metabolism in endometriosis. Ann NY Acad Sci 955:75-85
11. Laschke MW, Menger MD 2007 In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 13:331-342
12. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD 2006 Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 21:262-268
13. Laschke MW, Elitzsch A, Scheuer C, Vollmar B, Menger MD 2007 Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 87:163-171
14. Smith WL, Song I 2002 The enzymology of prostaglandin endoperoxide H synthases-1 and -2. Prostagland Other Lipid Mediat 68-69:115-128
15. Narumiya S, FitzGerald GA 2001 Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108:25-30
16. Wang D, Dubois RN 2006 Prostaglandins and cancer. Gut 55:115-122
17. Buchanan FG, Wang D, Bargiacchi F, DuBois RN 2003 Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 278:35451-35457
18. Cha YI, DuBois RN 2007 NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58:239-252
19. Jabbour HN, Sales KJ 2004 Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 15:398-404
20. Karck U, Reister F, Schafer W, Zahradnik HP, Breckwoldt M 1996 PGE2 and PGF2α release by human peritoneal macrophages in endometriosis. Prostaglandins 51:49-60
21. Allen C, Hopewell S, Prentice A 2005 Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2005:CD004753
22. Chishima F, Hayakawa S, Sugita K, Kinukawa N, Aleemuzzaman S, Nemoto N, Yamamoto T, Honda M 2002 Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 48:50-56
23. Ota H, Igarashi S, Sasaki M, Tanaka T 2001 Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 16:561-566
24. Ebert AD, Bartley J, David M 2005 Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions-old answers? Eur J Obstet Gynecol Reprod Biol 122:144-150
25. Zeitoun KM, Bulun SE 1999 Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 72:961-969
26. Matsuzaki S, Canis M, Darcha C, Dallel R, Okamura K, Mage G 2004 Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 82:1609-1615
27. Ozawa Y, Murakami T, Tamura M, Terada Y, Yaegashi N, Okamura K 2006 A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice. Fertil Steril 86(Suppl 4):1146-1151
28. Efstathiou JA, Sampson DA, Levine Z, Rohan RM, Zurakowski D, Folkman J, D'Amato RJ, Rupnick MA 2005 Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model. Fertil Steril 83:171-181
29. Banu SK, Lee J, Starzinski-Powitz A, Arosh JA, Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells. Fertil Steril, in press
30. American Society for Reproductive Medicine 1997 Revised American Society for Reproductive Medicine Classification of Endometriosis: 1996. Fertil Steril 67:817-821
31. Desai NN, Kennard EA, Kniss DA, Friedman CI 1994 Novel human endometrial cell line promotes blastocyst development. Fertil Steril 61:760-766
32. Krikun G, Mor G, Alvero A, Guller S, Schatz F, Sapi E, Rahman M, Caze R, Qumsiyeh M, Lockwood CJ 2004 A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 145:2291-2296
33. Asselin E, Lacroix D, Fortier MA 1997 IFN-τ increases PGE2 production and COX-2 gene expression in the bovine endometrium in vitro. Mol Cell Endocrinol 132:117-126
34. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L, Shim H 2005 Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65:967-971
35. Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK, Nie S, Umbreit J, Shim H 2004 Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64:4302-4308
36. Arosh JA, Banu SK, Chapdelaine P, Emond V, Kim JJ, MacLaren LA, Fortier MA 2003 Molecular cloning and characterization of bovine prostaglandin E2 receptors EP2 and EP4: expression and regulation in endometrium and myometrium during the estrous cycle and early pregnancy. Endocrinology 144:3076-3091
37. Kumagai N, Yamamoto K, Fukuda K, Nakamura Y, Fujitsu Y, Nuno Y, Nishida T 2002 Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis. J Allergy Clin Immunol 110:489-491
38. Bellosta S, Gomaraschi M, Canavesi M, Rossoni G, Monetti M, Franceschini G, Calabresi L 2006 Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection. FEBS Lett 580:5974-5978
39. Banu SK, Lee J, Satterfield MC, Spencer TE, Bazer FW, Arosh JA 2008 Molecular cloning and characterization of prostaglandin transporter in ovine endometrium: role of mitogen activated protein kinase pathways in release of prostaglandin F2α. Endocrinology 149:219-231
40. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
41. Satoh MS, Lindahl T 1992 Role of poly(ADP-ribose) formation in DNA repair. Nature 356:356-358
42. Nagase H, Woessner Jr JF 1999 Matrix metalloproteinases. J Biol Chem 274:21491-21494
43. Adams JM, Cory S 1998 The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326
44. Trifan OC, Hla T 2003 Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 7:207-222
45. Witz CA, Dechaud H, Montoya-Rodriguez IA, Thomas MR, Nair AS, Centonze VE, Schenken RS 2002 An in vitro model to study the pathogenesis of the early endometriosis lesion. Ann NY Acad Sci 955:296-307
46. Witz CA 2002 Pathogenesis of endometriosis. Gynecol Obstet Invest 53(Suppl 1):52-62
47. Witz CA, Allsup KT, Montoya-Rodriguez IA, Vaughan SL, Centonze VE, Schenken RS 2003 Pathogenesis of endometriosis: current research. Hum Fertil (Camb) 6:34-40
48. Callejas NA, Casado M, Diaz-Guerra MJ, Bosca L, Martin-Sanz P 2001 Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 33:860-867
49. Larkins TL, Nowell M, Singh S, Sanford GL 2006 Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 6:181
50. Curry Jr TE, Osteen KG 2003 The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 24:428-465
51. Bruner-Tran KL, Zhang Z, Eisenberg E, Winneker RC, Osteen KG 2006 Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget. J Clin Endocrinol Metab 91:1554-1560
52. Otto JC, DeWitt DL, Smith WL 1993 N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J Biol Chem 268:18234-18242